Alpha-phenyl-alpha(2,3-cyclohexenyl) acetic acid derivatives as potential antispasmodics.
D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003509:Cyclohexanecarboxylic Acids / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000627:therapeutic use*; D003864:Depression, Chemical; D004285:Dogs; D004336:Drug Antagonism; D004602:Elements / Q000032:analysis*; D005260:Female; D005730:Ganglionic Blockers / Q000627:therapeutic use*; D006168:Guinea Pigs; D008297:Male; D051379:Mice; D009132:Muscles / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use*; D010648:Phenylacetates / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D013566:Sympathomimetics / Q000627:therapeutic use*; D014203:Tremorine / Q000494:pharmacology*
D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D004602:Elements; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D010648:Phenylacetates; D013566:Sympathomimetics; D014203:Tremorine